FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168966017> ?p ?o ?g. }

• W3168966017 endingPage "724" @default.
• W3168966017 startingPage "716" @default.
• W3168966017 abstract "To compare effects of intravenous (IV) alfaxalone with ketamine-xylazine combination on anaesthetic induction, recovery and cardiopulmonary variables in mute swans.Randomized, controlled, clinical study.A group of 58 mute swans.Swans were given either alfaxalone (10 mg kg-1; group A) or a combination of ketamine (12.5 mg kg-1) and xylazine (0.28 mg kg-1) (group KX) IV. Heart and respiratory rates, end-tidal carbon dioxide and peripheral haemoglobin oxygen saturation were recorded at 5 minute intervals during anaesthesia. Time from anaesthetic induction to intubation, from cessation of isoflurane to extubation, to lifting head, sternal recumbency and absence of head/neck ataxia were recorded. Anaesthetic and recovery quality were scored (1 = very poor; 5 = excellent). Data are presented as median (interquartile range). Significance was set at p < 0.05.In group A, 44% (12/27) of swans required mechanical ventilation for 2-14 minutes versus 3.2% (1/31) of swans in group KX (p = 0.0002). Heart rate was higher in group A than in group KX [146 (127-168) versus 65.5 (56-78) beats minute-1, respectively; p < 0.0001]. The isoflurane concentration required to maintain anaesthesia was higher in group A than in group KX [2.5% (2.0-3.0%) versus 1.5% (1.0-2.0%), respectively; p = 0.0001]. Time from cessation of isoflurane administration to lifting head was significantly longer in group A than in group KX [12 (9-17) versus 6 (4-7.75) minutes, respectively; p < 0.0001]. Anaesthesia quality scores were significantly better in group KX than in group A [4 (4-5) versus 4 (3-4), respectively; p = 0.0011], as were recovery scores [4 (3-5) versus 2 (2-3), respectively; p = 0.0005].Alfaxalone is a suitable anaesthetic induction agent for use in mute swans. There is a greater incidence of postinduction apnoea and a higher incidence of agitation on recovery with alfaxalone than with ketamine-xylazine." @default.
• W3168966017 created "2021-06-22" @default.
• W3168966017 creator A5003354747 @default.
• W3168966017 creator A5018876360 @default.
• W3168966017 creator A5047988732 @default.
• W3168966017 date "2021-09-01" @default.
• W3168966017 modified "2023-09-26" @default.
• W3168966017 title "A comparison of the pharmacodynamic effects of intravenous ketamine–xylazine with alfaxalone in mute swans (Cygnus olor) presenting at a wildlife veterinary hospital" @default.
• W3168966017 cites W1506681842 @default.
• W3168966017 cites W1595887004 @default.
• W3168966017 cites W1996540722 @default.
• W3168966017 cites W2001672983 @default.
• W3168966017 cites W2081196440 @default.
• W3168966017 cites W2100815586 @default.
• W3168966017 cites W2112864155 @default.
• W3168966017 cites W2124488788 @default.
• W3168966017 cites W2126305823 @default.
• W3168966017 cites W2133067050 @default.
• W3168966017 cites W2143874717 @default.
• W3168966017 cites W2144753792 @default.
• W3168966017 cites W2147740257 @default.
• W3168966017 cites W2151969768 @default.
• W3168966017 cites W2158755528 @default.
• W3168966017 cites W2159562512 @default.
• W3168966017 cites W2320252769 @default.
• W3168966017 cites W2567398244 @default.
• W3168966017 cites W2603138125 @default.
• W3168966017 cites W2770658058 @default.
• W3168966017 cites W2782164987 @default.
• W3168966017 cites W2901522523 @default.
• W3168966017 cites W2994763836 @default.
• W3168966017 cites W4232244453 @default.
• W3168966017 cites W4253641189 @default.
• W3168966017 cites W4256093714 @default.
• W3168966017 doi "https://doi.org/10.1016/j.vaa.2021.03.014" @default.
• W3168966017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34340944" @default.
• W3168966017 hasPublicationYear "2021" @default.
• W3168966017 type Work @default.
• W3168966017 sameAs 3168966017 @default.
• W3168966017 citedByCount "2" @default.
• W3168966017 countsByYear W31689660172023 @default.
• W3168966017 crossrefType "journal-article" @default.
• W3168966017 hasAuthorship W3168966017A5003354747 @default.
• W3168966017 hasAuthorship W3168966017A5018876360 @default.
• W3168966017 hasAuthorship W3168966017A5047988732 @default.
• W3168966017 hasConcept C127413603 @default.
• W3168966017 hasConcept C200457457 @default.
• W3168966017 hasConcept C2776359302 @default.
• W3168966017 hasConcept C2779591255 @default.
• W3168966017 hasConcept C2780795376 @default.
• W3168966017 hasConcept C42219234 @default.
• W3168966017 hasConcept C71924100 @default.
• W3168966017 hasConcept C78519656 @default.
• W3168966017 hasConceptScore W3168966017C127413603 @default.
• W3168966017 hasConceptScore W3168966017C200457457 @default.
• W3168966017 hasConceptScore W3168966017C2776359302 @default.
• W3168966017 hasConceptScore W3168966017C2779591255 @default.
• W3168966017 hasConceptScore W3168966017C2780795376 @default.
• W3168966017 hasConceptScore W3168966017C42219234 @default.
• W3168966017 hasConceptScore W3168966017C71924100 @default.
• W3168966017 hasConceptScore W3168966017C78519656 @default.
• W3168966017 hasIssue "5" @default.
• W3168966017 hasLocation W31689660171 @default.
• W3168966017 hasLocation W31689660172 @default.
• W3168966017 hasOpenAccess W3168966017 @default.
• W3168966017 hasPrimaryLocation W31689660171 @default.
• W3168966017 hasRelatedWork W1894722280 @default.
• W3168966017 hasRelatedWork W1967105122 @default.
• W3168966017 hasRelatedWork W1970051514 @default.
• W3168966017 hasRelatedWork W2013094860 @default.
• W3168966017 hasRelatedWork W2093906336 @default.
• W3168966017 hasRelatedWork W2322288739 @default.
• W3168966017 hasRelatedWork W2412958953 @default.
• W3168966017 hasRelatedWork W3199216934 @default.
• W3168966017 hasRelatedWork W4206842453 @default.
• W3168966017 hasRelatedWork W4290703342 @default.
• W3168966017 hasVolume "48" @default.
• W3168966017 isParatext "false" @default.
• W3168966017 isRetracted "false" @default.
• W3168966017 magId "3168966017" @default.
• W3168966017 workType "article" @default.